Callan JMB

Callan JMB CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Callan JMB (CJMB) as of Nov 20, 2026 is -13.57 %. In the previous year, CapEx to Operating Cash Flow Ratio was 8.54 % — a change of -258.80% (lower).

CapEx/OCF

-13.57 %

YoY

-258.80%

Last updated:

CapEx to Operating Cash Flow Ratio of Callan JMB is 2025 -13.57 % . CapEx to Operating Cash Flow Ratio of Callan JMB was 2024 8.54 % . It decreases by -258.80% lower compared to the previous year.

The Callan JMB CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2022
4.51 USD
Jan 1, 2023
7.00 USD
Jan 1, 2024
8.54 USD
Jan 1, 2025
-13.57 USD
The Callan JMB CapEx/OCF history
YEARCapEx/OCFYoY
-13.57 %-258.80%
8.54 %+21.97%
7.00 %+55.24%
4.51 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Callan JMB Stock analysis

What does Callan JMB do? Callan JMB Inc provides thermal management logistics solutions for the life sciences industry, including personalized medicine, cell therapies, and vaccines. The company's Ship2Q ultraviolet disinfection process ensures thermal reliability and cleanliness of packaging systems. Its vertically integrated model combines proprietary packaging, IT, and cold chain logistics expertise to serve clients requiring cryogenic or frozen shipping. The firm targets life sciences companies needing specialized shipping solutions for temperature-sensitive products. Callan JMB Inc's primary products include thermal management logistics services and the Ship2Q disinfection process. These solutions address the full range of frozen shipping needs in the life sciences sector. The company serves manufacturers of biopharmaceuticals, diagnostic materials, and other temperature-sensitive commodities. Its services ensure that shipping systems meet manufacturer specifications for fitness and thermal performance. The company's business model focuses on providing comprehensive alternatives to traditional logistics solutions for frozen shipping. It operates as a vertically integrated provider, handling all aspects of cold chain logistics from packaging to delivery. Callan JMB Inc's target clients are life sciences companies requiring reliable, temperature-controlled shipping for sensitive materials like cell lines, cord blood, and organs. The firm's proprietary technology differentiates it in the specialized logistics market. Callan JMB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Callan JMB stock

CapEx to Operating Cash Flow Ratio of Callan JMB is -13.57 % in 2025.

CapEx to Operating Cash Flow Ratio of Callan JMB changed from 8.54 % to -13.57 %, representing a -258.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Callan JMB since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Callan JMB with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Callan JMB

All Key Metrics — Callan JMB